Several therapeutic strategies for sepsis aim to modulate inflammatory responses such as low-dose glucocorticoids, C-reactive protein inhibitors, TNF-α and IL-1β receptor antagonists, recombinant IL-17, and PD-1 immunotherapy, etc. (Delano and Ward, 2016). The gene discussed is IL17A; the disease is Sepsis.